Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Biomolecules|March 28, 2026
Targeting LIPA with ERX-41 Induces ER Stress and Inhibits Tumor Progression in Inflammatory Breast CancerZenaida Fuentes, Gaurav Sharma, Bianca A Romo, et al.
Cancers|November 11, 2022
Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer GrowthLogan Blankenship, Uday P Pratap, Xue Yang, et al.
Mabs|January 31, 2019
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodiesNathan D Trinklein, Duy Pham, Ute Schellenberger, et al.
Cancer Letters|October 21, 2021
KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancerPrabhakar Pitta Venkata, Yihong Chen, Salvador Alejo, et al.
Breast Cancer Research : BCR|December 28, 2019
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancersSuryavathi Viswanadhapalli, Shihong Ma, Gangadhara Reddy Sareddy, et al.
Cell Death Discovery|August 17, 2021
LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancerWeiwei Tang, Kumaraguruparan Ramasamy, Sureshkumar M A Pillai, et al.
Cancer Letters|September 15, 2023
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancerPrabhakar Pitta Venkata, Sridharan Jayamohan, Yi He, et al.
NPJ Vaccines|July 12, 2024
Priming antibody responses to the fusion peptide in rhesus macaquesChristopher A Cottrell, Payal P Pratap, Kimberly M Cirelli, et al.
Frontiers in Immunology|May 10, 2018
Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific AntibodiesKatherine E Harris, Shelley Force Aldred, Laura M Davison, et al.
Pageof 10